Estudo teórico da interação 'Host-Guest' em modelos de clatratos

Autor: Follmann, Patrícia

Publikováno v: Repositório Institucional da UFSCUniversidade Federal de Santa CatarinaUFSC.

Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências Físicas e Matemáticas, Programa de Pós-Graduação em Química, 2015.
Made available in DSpace on 2016-10-19T12:44:10Z (GMT). No. of bitstreams: 1 341898.p

Externí odkaz: https://repositorio.ufsc.br/xmlui/handle/123456789/169343

Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed KMT2A-rearranged acute lymphoblastic leukemia: Children's Oncology Group trial AALL15P1.

Autor: Guest EM; Division of Hematology, Oncology, Bone Marrow Transplant, Children's Mercy Kansas City, University of Missouri-Kansas City School of Medicine, Kansas City, MO. eguest@cmh.edu., Kairalla JA; Department of Biostatistics, University of Florida, Gainesville, FL., Devidas M; St. Jude Children's Research Hospital, Memphis, TN., Hibbitts E; Department of Biostatistics, University of Florida, Gainesville, FL., Carroll AJ; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL., Heerema NA; Department of Pathology, The Ohio State University, Columbus, OH., Kubaney HR; Dell Children's Medical Center of Central Texas, Austin, TX., August MA; Health Informatics and Technology, Children's Mercy Kansas City, Kansas City, MO., Ramesh S; University of Pennsylvania, Philadelphia, PA., Yoo B; Research Informatics, Children's Mercy Kansas City, Kansas City, MO., Farooqi MS; Department of Pathology and Laboratory Medicine, Children's Mercy Kansas City, University of Missouri-Kansas City School of Medicine, Kansas City, MO., Pauly MG; Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta and Emory University, Atlanta, GA., Wechsler DS; Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta and Emory University, Atlanta, GA., Miles RR; University of Utah, Department of Pathology, Salt Lake City, UT., Reid JM; Mayo Clinic, Rochester, MN., Kihei CD; Saint Mary's Hospital, West Palm Beach, FL., Gore L; Children's Hospital Colorado, Center for Cancer and Blood Disorders, Denver, CO., Raetz EA; New York University Langone Health, New York, NY., Hunger SP; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Loh ML; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute and the Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, 98105., Brown PA; Bristol Myers Squibb, Princeton, NJ.

Publikováno v: Haematologica [Haematologica] 2024 Jun 13. Date of Electronic Publication: 2024 Jun 13.

Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy.

Autor: Cheung LC; Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA, Australia.; Curtin Medical School, Curtin University, Perth, WA, Australia.; Curtin Health Innovation Research Institute, Curtin University, Perth, WA, Australia., Aya-Bonilla C; Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA, Australia.; The University of Western Australia, Perth, WA, Australia., Cruickshank MN; The University of Western Australia, Perth, WA, Australia., Chiu SK; Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA, Australia., Kuek V; Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA, Australia.; Curtin Medical School, Curtin University, Perth, WA, Australia.; The University of Western Australia, Perth, WA, Australia., Anderson D; Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA, Australia., Chua GA; Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA, Australia., Singh S; Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA, Australia., Oommen J; Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA, Australia., Ferrari E; Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA, Australia., Hughes AM; Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA, Australia., Ford J; Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA, Australia., Kunold E; Department of Oncology-Pathology, Clinical Proteomics Mass Spectrometry, Karolinska Institutet, Science for Life Laboratory, Solna, Sweden., Hesselman MC; Department of Oncology-Pathology, Clinical Proteomics Mass Spectrometry, Karolinska Institutet, Science for Life Laboratory, Solna, Sweden., Post F; Department of Oncology-Pathology, Clinical Proteomics Mass Spectrometry, Karolinska Institutet, Science for Life Laboratory, Solna, Sweden., Faulk KE; University of Colorado Anschutz Medical Campus, Children's Hospital Colorado, Aurora, CO, USA., Breese EH; Cancer and Blood Diseases Institute, Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA., Guest EM; Division of Hematology, Oncology, Blood and Marrow Transplantation, Children's Mercy Kansas City, Kansas City, MO, USA., Brown PA; Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, John Hopkins University, Baltimore, MD, USA., Loh ML; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant and Cellular Therapy, Seattle Children's Hospital, Seattle, WA, USA., Lock RB; Children's Cancer Institute, Lowy Cancer Research Centre/School of Women's and Children's Health/UNSW Centre for Childhood Cancer Research, UNSW Sydney, Kensington, NSW, Australia., Kees UR; Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA, Australia.; The University of Western Australia, Perth, WA, Australia., Jafari R; Department of Oncology-Pathology, Clinical Proteomics Mass Spectrometry, Karolinska Institutet, Science for Life Laboratory, Solna, Sweden., Malinge S; Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA, Australia.; The University of Western Australia, Perth, WA, Australia., Kotecha RS; Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA, Australia. rishi.kotecha@health.wa.gov.au.; Curtin Medical School, Curtin University, Perth, WA, Australia. rishi.kotecha@health.wa.gov.au.; The University of Western Australia, Perth, WA, Australia. rishi.kotecha@health.wa.gov.au.; Department of Clinical Haematology, Oncology, Blood and Marrow Transplantation, Perth Children's Hospital, Perth, WA, Australia. rishi.kotecha@health.wa.gov.au.

Publikováno v: Leukemia [Leukemia] 2023 Jan; Vol. 37 (1), pp. 61-71. Date of Electronic Publication: 2022 Nov 15.

Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials.

Autor: Gupta S; Cancer Research Program, ICES, Toronto, ON, Canada; Institute for Health Policy, Evaluation and Management and Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada. Electronic address: sumit.gupta@sickkids.ca., Dai Y; Biostatistics, University of Florida, Gainesville, FL, USA., Chen Z; Biostatistics, University of Florida, Gainesville, FL, USA., Winestone LE; Department of Pediatrics, Benioff Children's Hospital and the Helen Diller Comprehensive Cancer Centre, University of California, San Francisco, San Francisco, CA, USA., Teachey DT; Cellular Therapy and Transplant Section and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Division of Oncology, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Bona K; Division of Population Sciences, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Aplenc R; Cellular Therapy and Transplant Section and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Division of Oncology, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Rabin KR; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA., Zweidler-McKay P; Department of Pediatrics Research, The University of Texas MD Anderson Cancer Centre, Houston, TX, USA; University of Texas MD Anderson UT Health Graduate School of Biomedical Sciences, Houston, TX, USA; ImmunoGen, Waltham, MA, USA., Carroll AJ; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA., Heerema NA; Department of Pathology, The Ohio State University Wexner School of Medicine, Columbus, OH, USA., Gastier-Foster J; Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, OH, USA; Department of Pediatrics, Ohio State University School of Medicine, Columbus, OH, USA., Borowitz MJ; Johns Hopkins University, Baltimore, MD, USA., Wood BL; Department of Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA., Maloney KW; Department of Pediatrics, University of Colorado and Children's Hospital Colorado, Aurora, CO, USA., Mattano LA Jr; HARP Pharma Consulting, Mystic, CT, USA., Larsen EC; Department of Pediatrics, Maine Children's Cancer Program, Scarborough, ME, USA., Angiolillo AL; Division of Oncology, Centre for Cancer and Blood Disorders, Children's National Hospital, Washington, DC, USA., Burke MJ; Division of Pediatric Hematology-Oncology, Medical College of Wisconsin, Milwaukee, WI, USA., Salzer WL; US Army Medical Research and Materiel Command, Fort Detrick, Frederick, MD, USA., Winter SS; Children's Hospitals and Clinics of Minnesota, Minneapolis, MN, USA., Brown PA; Johns Hopkins University, Baltimore, MD, USA., Guest EM; Genomic Medicine Centre, Children's Mercy Hospital, Kansas City, MO, USA., Dunsmore KP; Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, VA, USA., Kairalla JA; Biostatistics, University of Florida, Gainesville, FL, USA., Winick NJ; Simmons Cancer Center and Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA., Carroll WL; Department of Pediatrics, NYU Langone Health, New York City, NY, USA., Raetz EA; Department of Pediatrics, NYU Langone Health, New York City, NY, USA., Hunger SP; Division of Oncology, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Loh ML; Department of Pediatrics, Benioff Children's Hospital and the Helen Diller Comprehensive Cancer Centre, University of California, San Francisco, San Francisco, CA, USA., Devidas M; Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN, USA.

Publikováno v: The Lancet. Haematology [Lancet Haematol] 2023 Feb; Vol. 10 (2), pp. e129-e141.

Outstanding outcomes in infants with KMT2A -germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children's Oncology Group AALL0631 trial.

Autor: Guest EM; Division of Hematology/Oncology/Blood and Marrow Transplantation, Children's Mercy Kansas City, Kansas City, MO. eguest@cmh.edu., Kairalla JA; Department of Biostatistics, Colleges of Medicine, Public Health and Health Professions, University of Florida, Gainesville, FL., Hilden JM; Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO., Dreyer ZE; Texas Children's Hospital, Houston, TX., Carroll AJ; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL., Heerema NA; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Wang CY; Department of Biostatistics, Colleges of Medicine, Public Health and Health Professions, University of Florida, Gainesville, FL., Devidas M; Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN., Gore L; Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO., Salzer WL; U.S. Army Medical Research and Materiel Command, Fort Detrick, MD., Winick NJ; Division of Pediatric Hematology/Oncology, University of Texas Southwestern School of Medicine, Dallas, TX., Carroll WL; Department of Pediatrics and Perlmutter Cancer Center, NYU Langone Health, New York, NY., Raetz EA; Department of Pediatrics and Perlmutter Cancer Center, NYU Langone Health, New York, NY., Borowitz M; Departments of Pathology and Oncology, Johns Hopkins University, Baltimore, MD., Loh ML; Department of Pediatrics, Benioff Children's Hospital in the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Hunger SP; Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Brown PA; Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.

Publikováno v: Haematologica [Haematologica] 2022 May 01; Vol. 107 (5), pp. 1205-1208. Date of Electronic Publication: 2022 May 01.